Glactone Pharma AB

Glactone Pharma is developing novel drugs that target a key transcription factor signaling pathway for the treatment of advanced and treatment resistant cancers to improve the lives of cancer patients.

The company is founded on research that has demonstrated that the natural product galiellalactone can inhibit the growth of prostate cancer cells. With these results as starting point the company is focussed on discovering and developing novel drug like compounds that show efficacy in specific prostate cancer models.

Kategorier: Pharma

Gå till Glactone Pharma ABs hemsida